Phase II study of bevacizumab in patients with platinum-resistant ovarian cancer or peritoneal serous cancer. - Cannistra,S.A.; Matulonis,U.A.; Penson,R.T.; Hambleton,J.; Dupont,J.; Mackey,H.; Douglas,J.; Burger,R.A.; Armstrong,D.; Wenham,R.; McGuire,W. (J Clin Oncol, 2007)